Global Intravenous Solutions Market Research Report to 2026 - by Type, Composition Solution and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intravenous Solutions Market Research Report by Type, by Composition Solution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Intravenous Solutions Market size was estimated at USD 10,709.11 million in 2020, is expected to reach USD 11,621.52 million in 2021, and is projected to grow at a CAGR of 8.85% to reach USD 17,820.70 million by 2026.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Intravenous Solutions Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Intravenous Solutions Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Intravenous Solutions Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Intravenous Solutions Market?

4. What is the competitive strategic window for opportunities in the Global Intravenous Solutions Market?

5. What are the technology trends and regulatory frameworks in the Global Intravenous Solutions Market?

6. What is the market share of the leading vendors in the Global Intravenous Solutions Market?

7. What modes and strategic moves are considered suitable for entering the Global Intravenous Solutions Market?

Market Dynamics

Drivers

• Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
• Increasing Regulatory Approvals for Intravenous Solution Injections
• Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio

Restraints

• High Cost of Maintenance of Fluids

Opportunities

• Increase in Demand for Intravenous Solutions from Developing Economies
• Improvements and New Innovations in the Products for Patient Convenience
• Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer

Challenges

• Side Effects of Intravenous Fluids

Companies Mentioned

• Ajinomoto Co., Inc.
• Anhui Medipharm Co. Ltd
• Axa Parenterals Ltd
• B. Braun Melsungen AG
• Baxter International Inc
• Becton, Dickinson and Company
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Honeywell International Inc.
• ICU Medical, Inc.
• JW Life Science Corporation
• Nymak Pharma Ltd.
• Otsuka Holdings Co., Ltd.
• Salius Pharma Private Limited
• Schwitz Biotech
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Soxa Formulations & Research Pvt. Ltd.
• Terumo Corporation
• Varni Corporation
• Vifor Pharma Management Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/c6chba

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900